Veloxis Pharms Inc Drug Patent Portfolio
Veloxis Pharms Inc owns 1 orange book drug protected by 24 US patents Given below is the list of Veloxis Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8644239 | Method and apparatus for allocating and processing sequences in communication system | 30 Aug, 2028 | Active |
| US8664239 | Tacrolimus for improved treatment of transplant patients | 30 Aug, 2028 | Active |
| US8685998 | Tacrolimus for improved treatment of transplant patients | 30 Aug, 2028 | Active |
| US10166190 | Stabilized tacrolimus composition | 30 May, 2028 | Active |
| US10864199 | Tacrolimus for improved treatment of transplant patients | 30 May, 2028 | Active |
| US11110081 | Tacrolimus for improved treatment of transplant patients | 30 May, 2028 | Active |
| US11123331 | Tacrolimus for improved treatment of transplant patients | 30 May, 2028 | Active |
| US11419823 | Stabilized tacrolimus composition | 30 May, 2028 | Active |
| US12083103 | Tacrolimus for improved treatment of transplant patients | 30 May, 2028 | Active |
| US9549918 | Stabilized tacrolimus composition | 30 May, 2028 | Active |
| US10548880 | Solid dispersions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US11077096 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US7994214 | Solid dispersions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8486993 | Solid dispersions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8586084 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8591946 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8617599 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8623410 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8623411 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8889185 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US8889186 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US9161907 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US9757362 | Modified release compositions comprising tacrolimus | 30 Aug, 2024 | Expired |
| US9763920 | Solid dispersions comprising tacrolimus | 30 Aug, 2024 | Expired |
Latest Legal Activities on Veloxis Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Veloxis Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Jul, 2024 | US9549918 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 May, 2024 | US10864199 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 19 Jul, 2023 | US10548880 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Apr, 2023 | US9161907 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Jan, 2023 | US7994214 |
|
Recordation of Patent Grant Mailed
Critical
| 23 Aug, 2022 | US11419823 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Aug, 2022 | US11419823 |
|
Email Notification
Critical
| 04 Aug, 2022 | US11419823 |
|
Issue Notification Mailed
Critical
| 03 Aug, 2022 | US11419823 |
| Mailing Corrected Notice of Allowability | 26 Jul, 2022 | US11419823 |
|
Email Notification
Critical
| 26 Jul, 2022 | US11419823 |
| Corrected Notice of Allowability | 21 Jul, 2022 | US11419823 |
|
Pubs Case Remand to TC
Critical
| 17 Jul, 2022 | US11419823 |
| Dispatch to FDC | 11 Jul, 2022 | US11419823 |
|
Application Is Considered Ready for Issue
Critical
| 11 Jul, 2022 | US11419823 |
Veloxis Pharms Inc's Family Patents
Veloxis Pharms Inc drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 34.3% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Veloxis Pharms Inc Drug List
Given below is the complete list of Veloxis Pharms Inc's drugs and the patents protecting them.
1. Envarsus Xr
Envarsus Xr is protected by 24 patents, out of which 14 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8644239 | Method and apparatus for allocating and processing sequences in communication system |
30 Aug, 2028
(3 years from now)
| Active |
| US8664239 | Tacrolimus for improved treatment of transplant patients |
30 Aug, 2028
(3 years from now)
| Active |
| US8685998 | Tacrolimus for improved treatment of transplant patients |
30 Aug, 2028
(3 years from now)
| Active |
| US10166190 | Stabilized tacrolimus composition |
30 May, 2028
(3 years from now)
| Active |
| US10864199 | Tacrolimus for improved treatment of transplant patients |
30 May, 2028
(3 years from now)
| Active |
| US11110081 | Tacrolimus for improved treatment of transplant patients |
30 May, 2028
(3 years from now)
| Active |
| US11123331 | Tacrolimus for improved treatment of transplant patients |
30 May, 2028
(3 years from now)
| Active |
| US11419823 | Stabilized tacrolimus composition |
30 May, 2028
(3 years from now)
| Active |
| US12083103 | Tacrolimus for improved treatment of transplant patients |
30 May, 2028
(3 years from now)
| Active |
| US9549918 | Stabilized tacrolimus composition |
30 May, 2028
(3 years from now)
| Active |
| US10548880 | Solid dispersions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US11077096 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US7994214 | Solid dispersions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8486993 | Solid dispersions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8586084 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8591946 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8617599 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8623410 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8623411 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8889185 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US8889186 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US9161907 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US9757362 | Modified release compositions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
| US9763920 | Solid dispersions comprising tacrolimus |
30 Aug, 2024
(8 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Envarsus Xr's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List